Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
138.00    -7.00 (-4.83%)
Bid:
138.00
Ask:
144.50
Spread: 6.50 (4.71%)
Market Cap: £108.29m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Positive half year update

6 Jul 2005 07:00

Xaar PLC06 July 2005 FOR IMMEDIATE RELEASE 6 July 2005 Xaar plc POSITIVE HALF YEAR TRADING UPDATE Xaar plc ("Xaar"), the inkjet printing technology group headquartered inCambridge, presents an update on performance for the six months ended 30 June2005. Results Xaar is pleased to report that revenues for the six months to 30 June 2005 arein line with expectations at close to £20.0m (2004: £16.9m). Profit before tax for the period (and before foreign exchange movements oninter-company loans) is ahead of expectations at around £4.5m (2004: £2.4m on acomparable basis). These figures are stated under UK GAAP to be consistent withcurrent market forecasts. The results reflect a continuing growth in demand for the group's products andthe benefit of increased volumes on manufacturing overhead recovery. Cash at the end of June was in the region of £17.5m, up from £15.4m at the startof the year. This movement includes an increase in working capital and paymentof the final dividend for 2004 of £0.6m. The outlook for the full year continues to be positive. OmniDot Launch The group's OmniDot printhead platform, its new range of products co-developedwith Agfa (and named 'UPH' in its Agfa format), started commercial production inthe second quarter and was officially launched by Agfa at the FESPA tradeshowheld in May in Munich, Germany. FESPA represents the Screen Printing sector of the industry and digital printingaccounted for more than 50% of the stands at the show, with Xaar wellrepresented by its OEMs. Further details of Agfa's revolutionary new digitalinkjet press, the M-Press, and the Anapurna 100 wide format printer can be foundon the Agfa website, www.agfa.com. Announcement of interim results The interim results will be announced in accordance with Xaar's normal timetablein mid-September. The interim results will be prepared under IFRS in accordance with the EUdirective for quoted companies applicable for reporting periods starting on orafter 1 January 2005. The main differences between the two sets of reportingstandards, as they apply to the group, are likely to be in the capitalisation ofcertain research and development costs, the expensing of share option costs andmovements in the valuation of the group's US dollar hedging transactions. Contacts Xaar plc: 01223-423663Ian Dinwoodie, Chief Executive www.xaar.co.ukNigel Berry, Group Finance Director & Deputy Chief Executive Bankside Consultants:Steve Liebmann 020-7367-8883 / 07802-888159 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 202612:58 pmRNSTotal Voting Rights
28th May 20269:18 amRNSResult of AGM
6th May 20267:00 amRNSDirector/PDMR Shareholding
5th May 202611:36 amRNSHolding(s) in Company
30th Apr 20264:44 pmRNSHolding(s) in Company
16th Apr 20269:00 amRNSPublication of Annual Report and Notice of AGM
1st Apr 20263:43 pmRNSHolding(s) in Company
24th Mar 20267:05 amRNSFinal Results
23rd Mar 20263:33 pmRNS-RInvestor Presentation via Investor Meet Company
2nd Mar 20262:44 pmRNSTotal Voting Rights
14th Jan 20267:00 amRNSTrading Statement
5th Jan 202612:28 pmRNSTotal Voting Rights
5th Dec 20251:15 pmRNSHolding(s) in Company
1st Dec 202512:15 pmRNSTotal Voting Rights
24th Nov 202511:00 amRNSDirector/PDMR Shareholding
3rd Nov 20252:00 pmRNSTotal Voting Rights
21st Oct 20254:15 pmRNSDirector/PDMR Shareholding
13th Oct 20253:20 pmRNSHolding(s) in Company
2nd Oct 202511:10 amRNSDirector/PDMR Shareholding
2nd Oct 20258:50 amRNSDirector/PDMR Shareholding
1st Oct 20255:00 pmRNSDirector/PDMR Shareholding
1st Oct 20253:30 pmRNSTotal Voting Rights
1st Oct 202512:04 pmRNSTRADING UPDATE and NOTICE OF RESULTS
1st Sep 20254:30 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNS2025 INTERIM RESULTS
5th Aug 20257:00 amRNSBoard changes
1st Aug 20253:45 pmRNSTotal Voting Rights
14th Jul 202510:00 amRNSNotice of Interim Results
7th Jul 20253:30 pmRNSBlock listing Interim Review
2nd Jul 20253:30 pmRNSTotal Voting Rights
30th Jun 20252:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202510:00 amRNSTotal Voting Rights
28th May 20253:30 pmRNSResult of AGM
21st May 20251:00 pmRNSHolding(s) in Company
7th May 20253:30 pmRNSNotification of Transactions of Directors & PDMRs
2nd May 202510:30 amRNSTotal Voting Rights
15th Apr 20251:15 pmRNS2024 Annual Report and Notice of AGM
11th Apr 202512:00 pmRNSHolding(s) in Company
1st Apr 20254:15 pmRNSHolding(s) in Company
1st Apr 20253:30 pmRNSTotal Voting Rights
31st Mar 20253:45 pmRNSNotification of Transactions of Directors & PDMRs
31st Mar 20251:10 pmRNSHolding(s) in Company
28th Mar 202511:30 amRNSHolding(s) in Company
27th Mar 202511:00 amRNSHolding(s) in Company
25th Mar 20255:00 pmRNSNotification of Transactions of Directors & PDMRs
25th Mar 20257:00 amRNSFinal Results
5th Mar 202511:30 amRNSTotal Voting Rights
19th Feb 202510:30 amRNSHolding(s) in Company
10th Feb 202511:00 amRNSHolding(s) in Company
5th Feb 20254:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.